How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

Monday - Friday, 6:00 - 9:00 AM ET Honeywell's Quantinuum raises $1.68 billion in U.S. IPO as quantum computing heats up, Reuters reports United States Monday - Friday 6a ET Europe Monday - Friday ...

Need some questions to ask a girl you are interested in getting to know better? Completely understandable—that ultra important getting-to-know-you stage of any friendship or relationship can feel ...

Social Security provides retirement income for most working Americans, but future benefits may be reduced due to a growing retiree population. While Social Security is a critical source of income for ...